| NDUFB1 — NADH:ubiquinone Oxidoreductase Subunit B1 | |
|---|---|
| Symbol | NDUFB1 |
| Full Name | NADH:ubiquinone Oxidoreductase Subunit B1 (Complex I-B8) |
| Chromosome | 2q33.3 |
| NCBI Gene | 4706 |
| Ensembl | ENSG00000170733 |
| UniProt | O75489 |
| Protein Length | 104 amino acids |
| Protein Location | Inner mitochondrial membrane |
| Diseases | [PD](/diseases/parkinsons-disease), [AD](/diseases/alzheimers), [ALS](/diseases/als), Leigh syndrome, mitochondrial complex I deficiency |
NDUFB1 (also known as Complex I-B8 or NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 1) encodes a crucial accessory subunit of mitochondrial Complex I (NADH:ubiquinone oxidoreductase), the largest complex of the mitochondrial electron transport chain[1]. This gene is essential for normal electron transport chain function and has been increasingly recognized for its role in neurodegenerative diseases including Parkinson's Disease, Alzheimer's Disease, and Amyotrophic Lateral Sclerosis.
| Attribute | Value |
|---|---|
| Symbol | NDUFB1 |
| Full Name | NADH:ubiquinone Oxidoreductase Subunit B1 |
| Chromosomal Location | 2q33.3 |
| NCBI Gene ID | 4706 |
| Ensembl ID | ENSG00000170733 |
| UniProt ID | O75489 |
| Protein Length | 104 amino acids |
| Molecular Weight | ~11 kDa |
| Expression | Ubiquitous (highest in brain, heart, skeletal muscle) |
Complex I (NADH:ubiquinone oxidoreductase) is the largest respiratory chain complex in mammals, comprising 44 different subunits organized into multiple functional domains[2][3]:
NDUFB1 is classified as an accessory subunit located in the hydrophobic arm of Complex I[4]. It is one of 31 accessory subunits that do not participate directly in electron transfer but are essential for:
The protein is relatively small (104 amino acids) but plays a critical role in stabilizing the Complex I structure.
NDUFB1 contributes to the essential functions of Complex I in the electron transport chain[5]:
Complex I is crucial for oxidative phosphorylation in high-energy tissues:
NDUFB1 function impacts broader mitochondrial processes:
Complex I deficiency has been consistently documented in Parkinson's Disease[6][7]:
Pathophysiological mechanisms:
Genetic evidence:
Therapeutic implications:
In Alzheimer's Disease, mitochondrial dysfunction is an early event[8][9]:
Mechanisms:
Evidence:
Therapeutic approaches:
In ALS, mitochondrial dysfunction contributes to motor neuron degeneration:
Biallelic NDUFB1 mutations cause severe mitochondrial disease[10][11]:
NDUFB1 variants have been implicated in:
NDUFB1 is expressed ubiquitously with highest levels in:
The tissue-specific expression pattern reflects the high energy demands of these tissues.
Coenzyme Q10 (CoQ10)[12]
Mitochondrial protectants
Metabolic enhancers
Fearnley & Walker. Conservation of components of the mitochondrial complex I. Trends in Biochemical Sciences. 1992. ↩︎
Sazanov. A 3.3 Å resolution structure of human mitochondrial respiratory chain complex I. Biochimica et Biophysica Acta. 2015. ↩︎
Winkler et al. Molecular understanding of complex I. Current Opinion in Structural Biology. 2015. ↩︎
Brandt et al. NDUFB1 structure and assembly. Mitochondrion. 2019. ↩︎
Szeto et al. Mitochondrial dysfunction in neurodegeneration. Journal of Neurochemistry. 2017. ↩︎
Schapira AH. Mitochondrial complex I deficiency in Parkinson's disease. Journal of Neurology Neurosurgery Psychiatry. 2012. ↩︎
Chandra et al. Complex I mutations and mitochondrial dysfunction. Nature Reviews Neurology. 2019. ↩︎
Johnson et al. Mitochondrial complex I activity in Alzheimer's disease. Alzheimer's & Dementia. 2018. ↩︎
Moreira et al. Mitochondrial dysfunction and oxidative stress in aging brain. Ageing Research Reviews. 2020. ↩︎
Bhat et al. Complex I subunit mutations in Leigh syndrome. Brain. 2019. ↩︎
Chen et al. NDUFB1 variants causing mitochondrial disease. Journal of Medical Genetics. 2020. ↩︎
Martin et al. CoQ10 therapy for complex I deficiency. Molecular Genetics and Metabolism. 2022. ↩︎